Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
<p><strong>Background:</strong> Glutamine (Gln) is an abundant nutrient used by cancer cells. Breast cancers cells and particularly triple-receptor negative breast cancer (TNBC) are reported to be dependent on Gln to produce the energy required for survival and proliferation. Despi...
Main Authors: | Morotti, M, Zois, CE, El-Ansari, R, Craze, ML, Rakha, EA, Fan, S-J, Valli, A, Haider, S, Goberdhan, DCI, Green, AR, Harris, AL |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature
2020
|
Similar Items
-
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
by: Morotti, M, et al.
Published: (2019) -
Glutamine Uptake via SNAT6 and Caveolin Regulates Glutamine–Glutamate Cycle
by: Nikhil R. Gandasi, et al.
Published: (2021-01-01) -
Expression of Glutamine Transporter Slc38a3 (SNAT3) During Acidosis is Mediated by a Different Mechanism than Tissue-Specific Expression
by: Sarojini Balkrishna, et al.
Published: (2014-05-01) -
Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
by: Teoh, EJ, et al.
Published: (2017) -
Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis
by: Tayyaba Qureshi, et al.
Published: (2020-07-01)